Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins.

bacterial inclusion bodies combinatorial approach mild solubilization agents protein aggregates protein purification protein refolding

Journal

Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903

Informations de publication

Date de publication:
05 2020
Historique:
received: 18 09 2019
revised: 29 11 2019
accepted: 06 12 2019
pubmed: 20 1 2020
medline: 31 7 2021
entrez: 20 1 2020
Statut: ppublish

Résumé

Recombinant proteins expressed as bacterial inclusion bodies (IBs) are now receiving tremendous attention for many diverse applications in the areas of industrial and medical biotechnology. Understanding the structure-function relationship of protein in IBs has recently created new possibilities in developing innovative isolation, solubilization, refolding, and purification processes for high-throughput recovery of bioactive protein from bacterial IBs. This opinion article describes the advantages, disadvantages, and major challenges presently associated with each of the processing steps. Finally, we conclude with the possible solutions for each operational step and the future direction of the basic and translational research to achieve maximum benefit from IB aggregates.

Identifiants

pubmed: 31954528
pii: S0167-7799(19)30306-3
doi: 10.1016/j.tibtech.2019.12.011
pii:
doi:

Substances chimiques

Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

474-486

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Priyank Singhvi (P)

Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.

Ankit Saneja (A)

Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.

Sudeepa Srichandan (S)

Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.

Amulya K Panda (AK)

Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India. Electronic address: amulya@nii.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH